These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6165424

  • 1. Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors.
    Peckham MJ, Barrett A, McElwain TJ, Hendry WF, Raghavan D.
    Br J Urol; 1981 Apr; 53(2):162-72. PubMed ID: 6165424
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis.
    Raghavan D, Peckham MJ, Heyderman E, Tobias JS, Austin DE.
    Br J Cancer; 1982 Feb; 45(2):167-73. PubMed ID: 6174137
    [Abstract] [Full Text] [Related]

  • 3. Tumour-marker levels and prognosis in malignant teratoma of the testis.
    Germa-Lluch JR, Begent RH, Bagshawe KD.
    Br J Cancer; 1980 Dec; 42(6):850-5. PubMed ID: 6161630
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma.
    Stevens MJ, Norman AR, Dearnaley DP, Horwich A.
    J Clin Oncol; 1995 Jan; 13(1):87-92. PubMed ID: 7528272
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum tumour marker regression rate following chemotherapy for malignant teratoma.
    Horwich A, Peckham MJ.
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1463-70. PubMed ID: 6209145
    [Abstract] [Full Text] [Related]

  • 7. Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
    Peckham MJ, Barrett A, Husband JE, Hendry WF.
    Lancet; 1982 Sep 25; 2(8300):678-80. PubMed ID: 6126625
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
    Szymendera JJ, Zborzil J, Sikorowa L, Leńko J, Kamińska JA, Gadek A.
    Oncology; 1983 Sep 25; 40(1):1-10. PubMed ID: 6185897
    [Abstract] [Full Text] [Related]

  • 9. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
    Taylor RE, Duncan W, Davey P, Munro AJ, Cornbleet MA.
    Br J Urol; 1985 Oct 25; 57(5):567-73. PubMed ID: 2415203
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mature and immature teratomas: results of the first paediatric Italian study.
    Lo Curto M, D'Angelo P, Cecchetto G, Klersy C, Dall'Igna P, Federico A, Siracusa F, Alaggio R, Bernini G, Conte M, De Laurentis T, Di Cataldo A, Inserra A, Santoro N, Tamaro P, Indolfi P.
    Pediatr Surg Int; 2007 Apr 25; 23(4):315-22. PubMed ID: 17333214
    [Abstract] [Full Text] [Related]

  • 12. Late relapse of testicular cancer.
    Baniel J, Foster RS, Gonin R, Messemer JE, Donohue JP, Einhorn LH.
    J Clin Oncol; 1995 May 25; 13(5):1170-6. PubMed ID: 7537800
    [Abstract] [Full Text] [Related]

  • 13. The role of abdominal surgery in the treatment of advanced testicular germ cell tumours.
    Jones BM, Newlands ES, Begent RH, Rustin GJ, Bagshawe KD, Johnson AG, Reynolds KW.
    Br J Surg; 1982 Jan 25; 69(1):4-6. PubMed ID: 6172177
    [Abstract] [Full Text] [Related]

  • 14. Testicular tumors of germ cell origin.
    Kaplan JH, Kudish HG, Sacks SA.
    Postgrad Med; 1981 Dec 25; 70(6):125-7, 130-1. PubMed ID: 6796949
    [Abstract] [Full Text] [Related]

  • 15. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
    Thomas R, Dearnaley D, Nicholls J, Norman A, Sampson S, Horwich A.
    Br J Cancer; 1996 Jul 25; 74(1):59-62. PubMed ID: 8679458
    [Abstract] [Full Text] [Related]

  • 16. Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies.
    Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR.
    Cancer; 1989 May 01; 63(9):1657-67. PubMed ID: 2467734
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR, Belitsky P, Millard OH, Lannon SG.
    Can J Surg; 1993 Dec 01; 36(6):537-40. PubMed ID: 7504978
    [Abstract] [Full Text] [Related]

  • 19. The investigation and treatment of germ cell tumours of the testis.
    Slater AJ, James KW, Fifield R, Groom GV.
    Clin Radiol; 1981 Jan 01; 32(1):25-30. PubMed ID: 6783360
    [Abstract] [Full Text] [Related]

  • 20. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D, Caillaud JM, Droz JP, Delarue JC, Bohuon C.
    Nouv Presse Med; 1981 Nov 07; 10(40):3293-7. PubMed ID: 6170931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.